Header cover image

Materials Healthcare Sector

Results

2304

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2304 companies

Outset Medical

Market Cap: US$329.6m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

OM

US$18.47

7D

-5.5%

1Y

-69.1%

Arcturus Therapeutics Holdings

Market Cap: US$329.5m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

ARCT

US$12.80

7D

10.0%

1Y

-59.0%

CytomX Therapeutics

Market Cap: US$321.4m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

CTMX

US$2.13

7D

6.5%

1Y

16.4%

Varex Imaging

Market Cap: US$317.2m

Designs, manufactures, and sells X-ray imaging components.

VREX

US$7.73

7D

-2.0%

1Y

-47.3%

iTeos Therapeutics

Market Cap: US$314.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

ITOS

US$8.69

7D

9.0%

1Y

-50.5%

Cytek Biosciences

Market Cap: US$314.1m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

CTKB

US$2.45

7D

-8.6%

1Y

-58.6%

Abeona Therapeutics

Market Cap: US$313.0m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$6.58

7D

13.6%

1Y

57.8%

Cryoport

Market Cap: US$307.8m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

CYRX

US$6.22

7D

-7.6%

1Y

-42.6%

Tvardi Therapeutics

Market Cap: US$306.3m

Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.

TVRD

US$32.88

7D

22.8%

1Y

n/a

National Research

Market Cap: US$305.1m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

NRC

US$13.79

7D

-1.4%

1Y

-54.4%

Cresco Labs

Market Cap: CA$417.6m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

CL

CA$0.95

7D

-5.9%

1Y

-64.0%

XOMA Royalty

Market Cap: US$300.6m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

XOMA

US$25.11

7D

-6.7%

1Y

0.1%

Aura Biosciences

Market Cap: US$299.6m

A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.

AURA

US$5.94

7D

14.7%

1Y

-19.1%

Pacific Biosciences of California

Market Cap: US$294.4m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

PACB

US$0.94

7D

-11.2%

1Y

-51.5%

Heron Therapeutics

Market Cap: US$286.8m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

HRTX

US$1.87

7D

0%

1Y

-46.1%

American Oncology Network

Market Cap: US$286.7m

Through its subsidiaries, provides oncology management services in the United States.

AONC

US$6.10

7D

-12.7%

1Y

186.4%

Aurora Cannabis

Market Cap: CA$395.7m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

ACB

CA$7.61

7D

10.1%

1Y

-13.9%

Compass Therapeutics

Market Cap: US$284.9m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

CMPX

US$2.10

7D

4.0%

1Y

40.5%

Canopy Growth

Market Cap: CA$392.3m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

WEED

CA$2.69

7D

42.3%

1Y

-78.5%

Corvus Pharmaceuticals

Market Cap: US$279.9m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

CRVS

US$3.47

7D

-3.1%

1Y

67.6%

Imricor Medical Systems

Market Cap: AU$434.4m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

IMR

AU$1.56

7D

-5.5%

1Y

249.4%

Immutep

Market Cap: AU$430.8m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

IMM

AU$0.29

7D

-3.3%

1Y

-33.7%

Sanara MedTech

Market Cap: US$275.7m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

SMTI

US$30.99

7D

0.4%

1Y

7.6%

Candel Therapeutics

Market Cap: US$274.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

CADL

US$5.42

7D

6.1%

1Y

-49.3%

Oceania Healthcare

Market Cap: NZ$463.5m

Owns and operates various care centers and retirement villages in New Zealand.

OCA

NZ$0.66

7D

1.5%

1Y

13.8%

Panamera Holdings

Market Cap: US$273.1m

Does not have significant operations.

PHCI

US$4.00

7D

-33.3%

1Y

300.0%

Phathom Pharmaceuticals

Market Cap: US$271.6m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

PHAT

US$4.23

7D

21.6%

1Y

-58.9%

Entrada Therapeutics

Market Cap: US$271.1m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

TRDA

US$7.62

7D

-6.2%

1Y

-49.3%

Quantum-Si

Market Cap: US$270.7m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

QSI

US$1.74

7D

17.6%

1Y

4.8%

EBR Systems

Market Cap: AU$417.6m

Develops implantable systems for wireless tissue stimulation.

EBR

AU$1.21

7D

9.0%

1Y

18.0%

SANUWAVE Health

Market Cap: US$266.7m

Operates as a medical device company in the United States and internationally.

SNWV

US$28.87

7D

-7.8%

1Y

313.9%

Neuronetics

Market Cap: US$263.9m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

STIM

US$3.99

7D

-7.2%

1Y

73.5%

Viemed Healthcare

Market Cap: US$263.6m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

VMD

US$6.52

7D

-3.3%

1Y

-5.5%

Alpha Tau Medical

Market Cap: US$263.5m

A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

DRTS

US$3.00

7D

1.4%

1Y

13.2%

Alumis

Market Cap: US$263.3m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

ALMS

US$4.84

7D

-9.5%

1Y

n/a

Terns Pharmaceuticals

Market Cap: US$261.6m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

TERN

US$2.94

7D

5.4%

1Y

-49.8%

Page 15 of 64